Use of bedaquiline in the chemotherapy regimen for multiple drug resistant tuberculosis in the HIV positive patient
https://doi.org/10.21292/2075-1230-2019-97-10-53-58
Abstract
The article describes a clinical case of the effective treatment of multiple drug resistant respiratory tuberculosis in the HIV positive patient. The chemotherapy regimen consisted of 5 anti-tuberculosis drugs, including bedaquiline, and 3 antiretroviral (ARV) drugs. The combined use of bedaquiline and ARV therapy did not result in any adverse reactions.
About the Authors
N. D. Pirogova
Regional Clinical TB Dispensary
Russian Federation
Russian Federation
Natalya D. Pirogova – Chief TB Expertof Tyumen Regional Health Department, Head Physician.
2a, Kurortnaya St., Tyumen, 625000
S. N. Leshok
Regional Clinical TB Dispensary
Russian Federation
Russian Federation
Svetlana N. Leshok– Head of Multiple Drug Resistant Tuberculosis Department no. 1, Phthisiologist.
2a, Kurortnaya St., Tyumen, 625000
L. V. Schipunova
Regional Clinical TB Dispensary
Russian Federation
Russian Federation
Lilya V. Schipunova – Phthisiologist of MultipleDrug Resistant Tuberculosis Department no. 1.
2a, Kurortnaya St., Tyumen, 625000
N. G. Beloborodova
Regional Clinical TB Dispensary;
Tyumen State Medical University
Russian Federation
Russian Federation
Nelly G. Beloborodova – Candidate of Medical Sciences, Phthisiologist.
2a, Kurortnaya St., Tyumen, 625000
References
1. Balasanyants G.S. Experience of using bedaquiline in the multimodality therapy of tuberculosis patients with concurrent HIV infection. Tuberculosis and Lung Diseases, 2017, no. 9, pp. 49-54. Available: https://doi.org/10.21292/2075-1230-2017-95-9-49-54 (In Russ.)
2. Use guidelines for Sirturo®. Change no. 3. ЛП-002281, 30.08.2016. Available: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=0b3a9860-f3e5-4312-8776-adf8a9014499&t= (Accessed 21.08.2019). (In Russ.)
3. Morozova T.I., Otpuschennikova O.N., Doktorova N.P., Danilov А.N. Experience of using bedaquiline in the treatment of pulmonary tuberculosis patients with multiple drug resistance. Tuberculosis and Lung Diseases, 2016, vol. 94, no. 2, pp. 29-35. (In Russ.)
4. Nechaeva O.B. Osnovnye pokazateli po tuberkulezu po Rossiyskoy Federatsii (za 2016 god predvaritelnye). [Main tuberculosis rates in the Russian Federation (preliminary for 2016)]. Available: http://mednet.ru/ru/novosti/1958-1503 2017-czniioiz-publikuet-predvaritelnye-dannye-po-tuberkulezu-za-2016-god. (Accessed: 02.09.2019).
5. Edict no. 951 by RF MoH as of 12.12.2014 On Approval of Guidelines for Improvement of Respiratory Tuberculosis Diagnostics and Treatment. Moscow, 2014. (In Russ.)
6. Tikhonova L.Yu., Sokolova V.V., Tarasyuk I.А., Ekimenko А.M., Cherenkova M.А., Kudlay D.А. Experience of treatment of multiple drug resistant tuberculosis patients with bedaquiline in Amur Region. Tuberculosis and Lung Diseases, 2018, vol. 96, no. 6, pp. 45-50. (In Russ.)
7. Federalnye klinicheskiye rekomendatsii po diagnostike i lecheniyu tuberkuleza organov dykhaniya s mnozhestvennoy i shirokoy lekarstennoy ustoichivostyu vozbuditelya. [Federal clinical recommendations for diagnosis and treatment of respiratory tuberculosis with multiple and extensive drug resistance]. Moscow, Tver, OOO Izd-vo Triada Publ., 2015, 72 p.
8. Borisov S.E., Dheda K., Enwerem M. et al. Effectiveness and safety of bedaquilinecontaining regimens in the treatment of MDR- and XDR-TB: a multicentre study. Eur. Respir. J., 2017, no. 49, 1700387 [https://doi.org/10.1183/13993003.00387-2017].
9. Ndjeka N., Conradie F., Schnippel K. et al. Treatment of drugresistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis. Int. J. Tuberc. Lung Dis., 2015, vol. 19, pp. 979-985.
Review
For citations:
Pirogova N.D., Leshok S.N., Schipunova L.V., Beloborodova N.G. Use of bedaquiline in the chemotherapy regimen for multiple drug resistant tuberculosis in the HIV positive patient. Tuberculosis and Lung Diseases. 2019;97(10):53-58. (In Russ.) https://doi.org/10.21292/2075-1230-2019-97-10-53-58
Views:
1410
Email this article 